Last update 30 Mar 2025

SHR-1905

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
AIO 001, AIO-001, GSK-5784283
+ [3]
Target
Action
inhibitors
Mechanism
TSLP inhibitors(Thymic stromal lymphopoietin inhibitors)
Inactive Indication-
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Chronic rhinosinusitis with nasal polypsPhase 2
China
04 Sep 2023
AsthmaPhase 2
China
17 Jan 2023
Respiratory DiseasesPhase 1
Australia
01 Dec 2023
Mild asthmaPhase 1
China
15 Jun 2021
Pulmonary Disease, Chronic ObstructiveIND Approval
China
01 May 2024
Moderate asthmaPreclinical
United States
24 Oct 2023
Severe asthmaPreclinical
United States
24 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
TSLP
-
lqtummguev(fuxhusrxpl) = exhibited in a slightly greater-than-dose-proportional manner from 50 to 600 mg wdrskzhrcw (mwjmpxmeui )
Positive
15 Jul 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free